Comparative effectiveness of statin therapy in patients with hypertension of high and very high cardiovascular risk in actual clinical practice in Irkutsk

Aim. To study lipid-lowering therapy in patients with high and very high risk of cardiovascular events (CVEs) at the outpatient and inpatient care stages in Irkutsk.Material and methods. We analyzed 260 discharge summaries of patients with hypertension of high and very high risk of CVEs for the seco...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	Кардиоваскулярная терапия и профилактика
المؤلفون الرئيسيون:	O. A. Ivanova, S. G. Kuklin, S. S. Sizova, T. A. Novoselova, L. R. Gaifullina
التنسيق:	مقال
اللغة:	الروسية
منشور في:	«SILICEA-POLIGRAF» LLC 2021-11-01
الموضوعات:	lipid-lowering therapy statins high and very high risk cardiovascular events morisky-green test
الوصول للمادة أونلاين:	https://cardiovascular.elpub.ru/jour/article/view/3073

مواد مشابهة

Statin therapy in patients with high and very high cardiovascular risk: an optimal approach
حسب: E. V. Sayutina, وآخرون
منشور في: (2020-11-01)

Efficacy and safety of inclisiran, evolocumab and alirocumab in patients with high, very high and extreme cardiovascular risk
حسب: N. G. Lozhkina, وآخرون
منشور في: (2025-04-01)

Lipid-lowering effect of combined therapy with high-intensity statins and CETP inhibitors: a Systematic Review and meta-analysis
حسب: Liubo Xiang, وآخرون
منشور في: (2025-05-01)

Hypertriglyceridemia is associated with long-term risk of cardiovascular events and specific comorbidity in very high-risk hypertensive patients
حسب: O. Ya. Korolyuk, وآخرون
منشور في: (2020-04-01)

A Cross Sectional Study on Adherence to Medication among Patients with Hypertension and/or Diabetes Attending One of the Tertiary Care Institutes of Ahmedabad City, Gujarat, India
حسب: Janak Patel, وآخرون
منشور في: (2024-11-01)

Adherence to antihypertensive medications and its determinants among adult hypertensive patients
حسب: Sindu Punna, وآخرون
منشور في: (2022-10-01)

Uncontrolled Hypertension among Older Hypertensive Patients and Their Drug Adherence Pattern
حسب: K. Umakalyani, وآخرون
منشور في: (2025-04-01)

Efficacy and safety of statin therapy in multimorbid outpatients with very high cardiovascular risk
حسب: N. V. Izmozherova, وآخرون
منشور في: (2020-07-01)

Landscape of Statin as a Cornerstone in Atherosclerotic Cardiovascular Disease
حسب: Cheng Yang, وآخرون
منشور في: (2023-12-01)

Hemodiyaliz Hastalarında Tedaviye Uyumun Değerlendirilmesi
حسب: Sultan Özkurt, وآخرون
منشور في: (2017-12-01)

From guidelines to practice: LDL-C achievement in very high cardiovascular risk patients – analysis of the EDHIPO MARCA registry
حسب: Brayan Daniel Cordoba-Melo, وآخرون
منشور في: (2025-09-01)

Evaluation of Very-High-Frequency Ultrasound Imaging Characteristics of Dermatofibroma
حسب: Dong B, وآخرون
منشور في: (2024-12-01)

Very High Frequency Ultrasonographic Features of Trichofolliculoma: An Observational Study
حسب: Dong B, وآخرون
منشور في: (2024-12-01)

The Association between Statin Use and Reduced Migraine Likelihood: A Comprehensive Analysis of Migraine Subtypes and Statin Types in a Nationwide Korean Cohort
حسب: Ho Suk Kang, وآخرون
منشور في: (2024-08-01)

Pharmacotherapy with statins in highand very high-risk elderly patients
حسب: V. V. Simerzin, وآخرون
منشور في: (2020-11-01)

Evaluation of medication adherence in Lebanese hypertensive patients
حسب: Mohammad Yassine, وآخرون
منشور في: (2019-04-01)

Factors associated to treatment adherence in elderly people with hypertension: A cross-sectional study in Ho Chi Minh city
حسب: Cao Nguyen Hoai Thuong, وآخرون
منشور في: (2022-07-01)

Peripheral polyneuropathy in patients receiving long-term statin therapy
حسب: Öner Özdogan
منشور في: (2019-10-01)

The impact of statin therapy in the COVID-19 patients with very high cardiovascular risk
حسب: Duygu Ersan Demirci, وآخرون
منشور في: (2023-03-01)

Prevalence of hypertension in adult population and adherence to treatment among hypertensives in an urban area
حسب: Gudipally Monica, وآخرون
منشور في: (2024-04-01)

Effect of high-intensity statin preloading on TIMI flow in patients presenting with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention
حسب: Ahmed Shawky Elserafy, وآخرون
منشور في: (2020-07-01)

Blazars at Very High Energies: Emission Modelling
حسب: Hélène Sol, وآخرون
منشور في: (2022-11-01)

Response to the Comment on “Examining the role of elective pelvic radiotherapy in patients diagnosed with high- and very high-risk non-metastatic prostate cancer”
حسب: István Nahaji, وآخرون
منشور في: (2026-01-01)

Knowledge about Disease, Medication Therapy, and Related Medication Adherence Levels among Patients with Hypertension
حسب: Anna Gavrilova, وآخرون
منشور في: (2019-10-01)

Investigation of very high cycle fatigue by thermographyc method
حسب: V. Crupi, وآخرون
منشور في: (2014-10-01)

Adherence to statin therapy in patients with high and very high cardiovascular risk in real clinical practice
حسب: V. I. Podzolkov, وآخرون
منشور في: (2020-03-01)

REAL PRACTICE OF STATINS USE AND ITS DEPENDENCE ON FOLLOW-UP IN THE SPECIALIZED MEDICAL CENTRE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (ACCORDING TO THE PROFILE REGISTER)
حسب: S. Yu. Martsevich, وآخرون
منشور في: (2015-09-01)

Lipid-Lowering Treatment and the Lipid Goals Attainment in Patients with a Very High Cardiovascular Risk
حسب: Anna Lis, وآخرون
منشور في: (2023-08-01)

High-intensity statin therapy yields better outcomes in acute coronary syndrome patients: a meta-analysis involving 26,497 patients
حسب: Shiyong Yu, وآخرون
منشور في: (2020-08-01)

EFFECTIVENESS OF ROSUVASTATIN IN VERY HIGH RISK CARDIOVASCULAR PATIENTS IN THE ACTUAL OUTPATIENT PRACTICE
حسب: V. P. Mikhin, وآخرون
منشور في: (2015-12-01)

Comparative Efficacy and Safety of Statin Monotherapy and Statin plus Ezetimibe Combination in a Real-World Setting
حسب: Marat V. Ezhov, وآخرون
منشور في: (2023-11-01)

Register of patients with familial hypercholesterolemia and patients of very high cardiovascular risk with lipid-lowering therapy underperformance (RENESSANS)
حسب: M. V. Yezhov, وآخرون
منشور في: (2019-06-01)

Statins in arterial hypertension treatment
حسب: O. N. Tkacheva, وآخرون
منشور في: (1970-01-01)

Damage evolution in the AlMg6 alloy during high and very high cycle fatigue
حسب: Mikhail Bannikov, وآخرون
منشور في: (2019-06-01)

Damage evolution in the AlMg6 alloy during high and very high cycle fatigue
حسب: Mikhail Bannikov, وآخرون
منشور في: (2019-07-01)

Rhabdomyolysis as a rare severe complication of statin therapy: differential diagnosis in real clinical practice (a clinical case)
حسب: A. V. Melekhov, وآخرون
منشور في: (2025-06-01)

The effects of statins on the function and differentiation of blood cells
حسب: Sajjad Chamani, وآخرون
منشور في: (2022-12-01)

Assessment of lipid profile when using lipid-lowering therapy (statins) in patients with coronary atherosclerosis
حسب: N. E. Gavrilova, وآخرون
منشور في: (2015-11-01)

Statins and highly sensitive cardiac troponins: cardiotoxicity or cross-reactivity?
حسب: A. M. Chaulin, وآخرون
منشور في: (2023-05-01)

A randomized controlled trial of statin therapy effect on androgen status and erectile function in men with high and very high cardiovascular risk (TRISTAN): rationale and study protocol
حسب: K. P. Raevskii, وآخرون
منشور في: (2025-06-01)